NEW YORK (GenomeWeb News) – The UK's Technology Strategy Board and the Biological Sciences Research Council are investing more than £4.5 million ($7.3 million) for 11 research and development projects using genomics-based technologies.
The UK groups said that the projects being funded seek to highlight the opportunities created by the decrease in cost, and increase in speed, in high-throughput sequencing technology and to enable the development of new products and processes in the human and animal health fields as well as the agricultural industry.
The lead partners of the of the projects that have received funding are Anglo Beef Processors; Aquapharm Biodiscovery; Biotica Technology; Cygnet Plant Breeders; Ingenza (two projects); Landcatch Natural Selection; Limagrain UK; Oxitec; Population Genetics Technologies; and Unilever.
The Technology Strategy Board said that it will invest £3.65 million in the projects, with six of the projects receiving investments totaling £936,000 from the BBSRC. Including contributions from the industrial partners, the total value of the 11 projects is nearly £9.2 million.
"There is considerable growth potential in genomic-using sectors and, given the significant role played by our commercial life sciences sector and our high-quality science base, the UK has the opportunity to gain a commercial advantage," Will Barton, the Technology Strategy Board's head of technology, said in a statement. "The challenge for UK business is to capitalise on the opportunity presented by these technological advances, and I believe this funding can support and encourage this."